Ingeborg Tinhofer

9PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 27, 2025
Integrating MALDI-MSI-Based Spatial Proteomics and Machine Learning to Predict Chemoradiotherapy Outcomes in Head and Neck Cancer.

Marta Grzeski, Patrick Moeller Jensen, Benjamin-Florian Hempel

|Feb 24, 2025
Targeting Chk1 and Wee1 kinases enhances radiosensitivity of 2D and 3D head and neck cancer models to X-rays and low/high-LET protons.

Emma Melia, Anne-Sophie Fisch, Ingeborg Tinhofer

|Jun 17, 2024
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass.

Stefan Habringer, Jana Ihlow, Karsten Kleo

|Apr 23, 2024
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma.

D Martin, F Rödel, S Hehlgans

|Apr 14, 2023
DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.

Bouchra Tawk, Katrin Rein, Christian Schwager

|Oct 14, 2021
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.

Bouchra Tawk, Ute Wirkner, Christian Schwager

Pageof 2

Frequent Collaborators

3 joint publications

Ulrich Keilholz

2 joint publications

Albrecht Stenzinger

2 joint publications

Amir Abdollahi

2 joint publications

Damian T Rieke